GGrantIndex
← Leaderboards

Dmitry Isaac Gabrilovich

Loyola University Chicago

Google Scholar ↗PubMed ↗ORCID ↗
$18,046,810
Attributed
$20,249,582
Total exposure
15
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2005–19
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$20,249,582 · 15

By mechanism

R01$15,601,329 · 7
P50$2,779,368 · 2
R21$1,054,232 · 2
P01$755,758 · 1
P30$44,895 · 1
R13$14,000 · 2

Top collaborators

Others in their field

Top investigators on “Tumor”

Research focus

TumorImmune ResponseImmuneDendritic CellsMalignant NeoplasmsMyeloid CellsCellsMyelogenousPlayMacrophageRegulationBaseResponseAntigensDefectImmunotherapyCancer PatientCell Differentiation ProcessSuppressor-Effector T-LymphocytesT-LymphocyteCell PhysiologyMolecularImmune SystemResearch Study

Grant awards (76)

Negative regulation of myeloid-derived suppressive cells in cancer$457,106
R01 · FY2019 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$79,154
R01 · FY2019 · CA · contact PI
Research Program: Immunology, Microenvironment and Metastasis$44,895
P30 · FY2019 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$493,744
R01 · FY2018 · CA · contact PI
Lipids and Myeloid Cell Function in Cancer$422,160
R01 · FY2018 · CA · contact PI
Mechanism of myeloid cell defect in cancer$311,376
R01 · FY2018 · CA · contact PI
Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment$269,629
P01 · FY2018 · CA · contact PI
Mechanism of myeloid cell defect in cancer$178,200
R01 · FY2018 · CA · contact PI
Negative regulation of myeloid-derived suppressive cells in cancer$26,818
R01 · FY2018 · CA · contact PI
Correction of myeloid cell defects in cancer$314,969
R01 · FY2017 · CA · contact PI
Mechanism of myeloid cell defect in cancer$311,376
R01 · FY2017 · CA · contact PI
Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment$274,075
P01 · FY2017 · CA · contact PI
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth$243,173
P50 · FY2017 · CA · contact PI
Regulation of Tumor Microenvironment in Cancer$380,866
R01 · FY2016 · CA · contact PI
Lipids and Myeloid Cell Function in Cancer$363,568
R01 · FY2016 · CA · contact PI
Correction of myeloid cell defects in cancer$314,969
R01 · FY2016 · CA · contact PI
Mechanism of myeloid cell defect in cancer$311,376
R01 · FY2016 · CA · contact PI
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth$232,673
P50 · FY2016 · CA · contact PI
Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment$212,054
P01 · FY2016 · CA · contact PI
Regulation of Tumor Microenvironment in Cancer$373,604
R01 · FY2015 · CA · contact PI
Lipids and Myeloid Cell Function in Cancer$357,447
R01 · FY2015 · CA · contact PI
Mechanism of myeloid cell defect in cancer$325,336
R01 · FY2015 · CA · contact PI
Correction of myeloid cell defects in cancer$306,680
R01 · FY2015 · CA · contact PI
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth$229,122
P50 · FY2015 · CA · contact PI
Regulation of Tumor Microenvironment in Cancer$394,854
R01 · FY2014 · CA · contact PI
Lipids and Myeloid Cell Function in Cancer$346,723
R01 · FY2014 · CA · contact PI
Molecular network regulating dendritic cell differentiation in cancer$325,071
R01 · FY2014 · CA · contact PI
Correction of myeloid cell defects in cancer$297,480
R01 · FY2014 · CA · contact PI
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth$229,084
P50 · FY2014 · CA · contact PI
Lipids and Myeloid Cell Function in Cancer$356,333
R01 · FY2013 · CA · contact PI
Molecular network regulating dendritic cell differentiation in cancer$315,016
R01 · FY2013 · CA · contact PI
Correction of myeloid cell defects in cancer$306,680
R01 · FY2013 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$259,468
R01 · FY2013 · CA · contact PI
Potentiating the Effects of Targeted and Cytotoxic Agents on Cell-Based Immunoth$228,065
P50 · FY2013 · CA · contact PI
P5 - P-53-Based Vaccine for Small Cell Lung Cancer$400,000
P50 · FY2012 · CA · contact PI
Lipids and Myeloid Cell Function in Cancer$353,168
R01 · FY2012 · CA · contact PI
Molecular network regulating dendritic cell differentiation in cancer$302,517
R01 · FY2012 · CA · contact PI
Correction of dendritic cells defects in cancer$276,841
R01 · FY2012 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$249,172
R01 · FY2012 · CA · contact PI
P5 - P-53-Based Vaccine for Small Cell Lung Cancer$316,958
P50 · FY2011 · CA · contact PI
Molecular network regulating dendritic cell differentiation in cancer$302,517
R01 · FY2011 · CA · contact PI
Correction of dendritic cells defects in cancer$276,841
R01 · FY2011 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$249,172
R01 · FY2011 · CA · contact PI
Correction of dendritic cells defects in cancer$3,246
R01 · FY2011 · CA · contact PI
P5 - P-53-Based Vaccine for Small Cell Lung Cancer$363,048
P50 · FY2010 · CA · contact PI
Molecular network regulating dendritic cell differentiation in cancer$311,873
R01 · FY2010 · CA · contact PI
Correction of dendritic cells defects in cancer$285,403
R01 · FY2010 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$256,879
R01 · FY2010 · CA · contact PI
Correction of dendritic cells defects in cancer$63,079
R01 · FY2010 · CA · contact PI
Correction of dendritic cells defects in cancer$508,515
R01 · FY2009 · CA · contact PI
P-53-Based Vaccine for Small Cell Lung Cancer$350,392
P50 · FY2009 · CA · contact PI
Correction of dendritic cells defects in cancer$284,976
R01 · FY2009 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$256,879
R01 · FY2009 · CA · contact PI
Correction of dendritic cells defects in cancer$59,572
R01 · FY2009 · CA · contact PI
Conference on Regulatory Myeloid Cells in Health and Diseases$6,000
R13 · FY2009 · CA · contact PI
Correction of dendritic cells defects in cancer$283,694
R01 · FY2008 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$247,903
R01 · FY2008 · CA · contact PI
Role of lipids in dendritic cell function$203,762
R21 · FY2008 · AI · contact PI
P-53-Based Vaccine for Small Cell Lung Cancer$186,853
P50 · FY2008 · CA · contact PI
P53 Based Vaccine for Small Cell Lung Cancer$303,647
R01 · FY2007 · CA · contact PI
Correction of Dendritic Cells Defects in Cancer$270,469
R01 · FY2007 · CA · contact PI
Role of lipids in dendritic cell function$249,000
R21 · FY2007 · AI · contact PI
Mechanism of dendritic cell differentiation in cancer$243,423
R01 · FY2007 · CA · contact PI
Conference on immune suppression in cancer$8,000
R13 · FY2007 · CA · contact PI
Correction of Dendritic Cells Defects in Cancer$278,547
R01 · FY2006 · CA · contact PI
Mechanism of dendritic cell differentiation in cancer$250,692
R01 · FY2006 · CA · contact PI
ATRA effect on myeloid cell differentiation in cancer$300,735
R21 · FY2005 · CA
Correction of Dendritic Cells Defects in Cancer$285,250
R01 · FY2005 · CA
Mechanism of dendritic cell differentiation in cancer$256,725
R01 · FY2005 · CA
ATRA effect on myeloid cell differentiation in cancer$300,735
R21 · FY2004 · CA
Correction of Dendritic Cells Defects in Cancer$285,250
R01 · FY2004 · CA
Mechanism of dendritic cell differentiation in cancer$256,725
R01 · FY2004 · CA
Correction of Dendritic Cells Defects in Cancer$280,875
R01 · FY2003 · CA
CORRECTION OF DENDRITIC CELLS DEFECTS IN CANCER$191,507
R01 · FY2001 · CA
CORRECTION OF DENDRITIC CELLS DEFECTS IN CANCER$167,732
R01 · FY2000 · CA
CORRECTION OF DENDRITIC CELLS DEFECTS IN CANCER$27,866
R01 · FY2000 · CA